CA
CA · CA · CA-DIN-02505541
REBLOZYL
ATC B03XA06
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerBRISTOL-MYERS SQUIBB CANADA
CountryCA (CA)
ATC codeB03XA06
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02505541",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "B03XA06",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "99492",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"LUSPATERCEPT"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code B03XA06.
- DKReblozylBristol-Myers Squibb Pharma EEIG
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- DKReblozylBristol-Myers Squibb Pharma EEIG
- PLReblozylBristol-Myers Squibb Pharma EEIG
- PLReblozylBristol-Myers Squibb Pharma EEIG
- NOReblozylBristol-Myers Squibb Pharma EEIG (1)
- 🇺🇸ReblozylCelgene Corporation
Access this data programmatically
Query REBLOZYL and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.